BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 32745733)

  • 1. Rationale and design of a prospective, randomized, controlled, multicenter study to evaluate the safety and efficacy of transcatheter heart valve replacement in female patients with severe symptomatic aortic stenosis requiring aortic valve intervention (Randomized researcH in womEn all comers wIth Aortic stenosis [RHEIA] trial).
    Eltchaninoff H; Bonaros N; Prendergast B; Nietlispach F; Vasa-Nicotera M; Chieffo A; Pibarot P; Bramlage P; Sykorova L; Kurucova J; Bax JJ; Windecker S; Dumonteil N; Tchetche D
    Am Heart J; 2020 Oct; 228():27-35. PubMed ID: 32745733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.
    Pibarot P; Salaun E; Dahou A; Avenatti E; Guzzetti E; Annabi MS; Toubal O; Bernier M; Beaudoin J; Ong G; Ternacle J; Krapf L; Thourani VH; Makkar R; Kodali SK; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Leipsic J; Blanke P; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Szeto WY; Généreux P; Pershad A; Alu MC; Xu K; Rogers E; Webb JG; Smith CR; Mack MJ; Leon MB; Hahn RT;
    Circulation; 2020 May; 141(19):1527-1537. PubMed ID: 32272848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
    Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T;
    Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
    Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.
    Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.
    Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ;
    JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed Tomography-Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch.
    Head SJ; Reardon MJ; Deeb GM; Van Mieghem NM; Popma JJ; Gleason TG; Williams MR; Radhakrishnan S; Fremes S; Oh JK; Chang Y; Boulware MJ; Kappetein AP
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007396. PubMed ID: 30929507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.
    Kleiman NS; Van Mieghem NM; Reardon MJ; Gada H; Mumtaz M; Olsen PS; Heiser J; Merhi W; Chetcuti S; Deeb GM; Chawla A; Kiaii B; Teefy P; Chu MWA; Yakubov SJ; Windecker S; Althouse AD; Baron SJ
    JACC Cardiovasc Interv; 2024 Apr; 17(8):979-988. PubMed ID: 38658126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Flow on Prosthesis-Patient Mismatch Following Transcatheter and Surgical Aortic Valve Replacement.
    Abbas AE; Ternacle J; Pibarot P; Xu K; Alu M; Rogers E; Hahn RT; Leon M; Thourani VH
    Circ Cardiovasc Imaging; 2021 Aug; 14(8):e012364. PubMed ID: 34387097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
    Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications After Self-expanding Transcatheter or Surgical Aortic Valve Replacement.
    Conte JV; Hermiller J; Resar JR; Deeb GM; Gleason TG; Adams DH; Popma JJ; Yakubov SJ; Watson D; Guo J; Zorn GL; Reardon MJ
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):321-330. PubMed ID: 29195573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement.
    Gleason TG; Schindler JT; Adams DH; Reardon MJ; Kleiman NS; Caplan LR; Conte JV; Deeb GM; Hughes GC; Chenoweth S; Popma JJ
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):85-96. PubMed ID: 27085389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk.
    Baron SJ; Wang K; House JA; Magnuson EA; Reynolds MR; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Mack MJ; Brown DL; Russo MJ; Smith CR; Webb J; Miller C; Leon MB; Cohen DJ
    Circulation; 2019 Feb; 139(7):877-888. PubMed ID: 30586747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Wait-Time Mortality for Severe Aortic Stenosis: A Population-Level Study of the Transition in Practice From Surgical Aortic Valve Replacement to Transcatheter Aortic Valve Replacement.
    Albassam O; Henning KA; Qiu F; Cram P; Sheth TN; Ko DT; Woodward G; Austin PC; Wijeysundera HC
    Circ Cardiovasc Interv; 2020 Nov; 13(11):e009297. PubMed ID: 33167700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial.
    Rodés-Cabau J; Ribeiro HB; Mohammadi S; Serra V; Al-Atassi T; Iñiguez A; Vilalta V; Nombela-Franco L; Sáez de Ibarra Sánchez JI; Auffret V; Forcillo J; Conradi L; Urena M; Moris C; Muñoz-Garcia A; Paradis JM; Dumont E; Kalavrouziotis D; Maria Pomerantzeff P; Rosa VEE; Pezzute Lopes M; Sureda C; Diaz VAJ; Giuliani C; Avvedimento M; Pelletier-Beaumont E; Pibarot P;
    Circulation; 2024 Feb; 149(9):644-655. PubMed ID: 37883682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement.
    Pineda AM; Kevin Harrison J; Kleiman NS; Reardon MJ; Conte JV; O'Hair DP; Chetcuti SJ; Huang J; Yakubov SJ; Popma JJ; Beohar N
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):740-748. PubMed ID: 30341970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial.
    Thyregod HG; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Hansen PB; Andersen LW; Olsen PS; Søndergaard L
    J Am Coll Cardiol; 2015 May; 65(20):2184-94. PubMed ID: 25787196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mid-term outcomes of Sapien 3 versus Perimount Magna Ease for treatment of severe aortic stenosis.
    Virtanen MPO; Eskola M; Savontaus M; Juvonen T; Niemelä M; Laakso T; Husso A; Jalava MP; Tauriainen T; Ahvenvaara T; Maaranen P; Kinnunen EM; Dahlbacka S; Laine M; Mäkikallio T; Valtola A; Raivio P; Rosato S; D'Errigo P; Vento A; Airaksinen J; Biancari F
    J Cardiothorac Surg; 2020 Jun; 15(1):157. PubMed ID: 32600369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.